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Over the last several decades there has been great progress
with respect to understanding the triggers of most neuro-
degenerative diseases. For example, genetics studies have
identified mutations in superoxide dismutase 1 (SOD1)
gene that clearly cause amyotrophic lateral sclerosis. How-
ever ask a panel of experts how a mutation in SOD1
causes motor neurons to die and one will receive many
different hypothetical answers. There is simply insuffi-
cient data to unequivocally support one hypothesis over
another. With rare exceptions, this is true for almost all
neurodegenerative diseases.
In this review series, we have invited seminal researchers
in the field of neurodegeneration to critically review the
pathways that potentially lead to neurodegeneration.
These reviews include both disease specific reviews (e.g.,
the role of alpha-synuclein in driving neuronal death in
Parkinson's disease) as well as more general reviews that
focus on a pathway or a process that could lead to neuro-
degeneration (e.g., the role of autophagy in neurodegen-
eration).
As one of us describes in detail in the introductory review
"The therapeutic importance of understanding mecha-
nisms of neuronal cell death in neurodegenerative dis-
eases" the effort to understand the precise pathway that
lead to neuronal death is not simply academic. It has
major implications in developing new therapies that
might actually modify the disease process. By providing a
"state of the field", it is our hope that this review series will
reinvigorate efforts to conduct research that will ulti-
mately answer the question, "What kills neurons in neu-
rodegenerative diseases?" In each of the reviews, we have
asked the authors to not only provide a comprehensive
review of the key observations that demonstrate the
importance of a specific protein or pathway in neurode-
generation but also highlight the "critical next steps"
needed to shed light on the many enigmatic aspects of
neurodegeneration.
Over 20 review articles will appear in this series during
2009. These reviews, published in the open access form in
Molecular Neurodegeneration, will allow broad public
access. Given the flexibility of this publishing format and
the wide range of subject matter that could be addressed,
we encourage those wishing to contribute substantive
reviews of material not currently covered to contact either
of us to discuss a potential submission.
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